One drop of NEVANAC should be applied to the affected eye three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.
NEVANAC® may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.
If more than one topical ophthalmic medication is being used, the medicines must be administered at least 5 minutes apart.
Sterile ophthalmic suspension: 0.1% 3 mL in a 4 mL bottle
NEVANAC® (nepafenac ophthalmic suspension) is supplied in a natural, oval, low density polyethylene DROP-TAENER® dispenser with a natural low density polyethylene dispensing plug and gray polypropylene cap. Tamper evidence is provided with a shrink band around the closure and neck area of the package.
3 mL in 4 mL bottle         NDC 0065-0002-03
Storage: Store at 2 - 25°C (36 - 77°F).
Alcon Laboratories, Inc. Fort Worth, Texas 76134.  Revised: 06/2011
